Long COVID-19 and MAB Study

MultiCare Health System Research Institute

Status: Enrolling

Conditions: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT05508295

02/01/2022

Details and patient eligibility

About

This study will be observational only. It will provide real-world evidence generated from a representative and large-scale COVID patient base. The adoption, pilot testing and use of NIH PROs among viral tested patients with research purpose on long COVID will be unique and innovative. With the existing and proven scientific rigor, NIH PRO system will be adopted, then modified and tailored to form the long hauler specific, comprehensive instrument, helping generalize future knowledge regarding COVID-infected patients.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have been tested for COVID at one of the MultiCare facilities,
• AND 18 years old or older at the viral test,
• AND have no problem understanding English or Spanish.

Exclusion criteria

• Pediatric patients younger than 18 years old at the time of testing,
• OR patients who are pregnant,
• OR patients who plan to get pregnant in 3 months,
• OR patients who are hospitalized at the time of recruitment,
• OR patients who have cognitive impairment(s) at the recruitment.

Trial design

300 participants in 3 patient groups

COVID positive case with mAb treatment

COVID positive case having not received mAb treatment

COVID negative cases